NAMS

NewAmsterdam Pharma Co N.V.

CIK 0001936258 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations

$27.87

↑ 0.09 (0.32%)

as of Aug 21, 2026

End-of-day close, not real-time intraday

Live price (Google Finance) ↗

Overall read: NeutralOverall score · based on 4/4 lenses

FundamentalsOwnershipTechnicalsOptions

Bullish: Options; Risks: Fundamentals, Technicals

Key stats

Market Cap

$3.26B

P/E Ratio

-12.56

EPS

-1.72

Dividend Yield

Not covered

52W Position

25%

Beta

1.02

Valuation multiples

Fwd P/E

Not covered

PEG

Not covered

P/B

5.16

P/S

457.54

EV/Revenue

397.97

ROE

-41.1%

Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 25%

$23.05$42.20

Latest Financials

2025-12-31 FY

Revenue

$22.50M

Net Income

-$203.82M

Total Assets

$769.28M

Free Cash Flow

–

NAMS

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news

NAMS

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news